openPR Logo
Press release

Learn Details of the Global Giardiasis Treatment Market

Giardiasis is a bowel infection caused by microscopic parasite known as Giardia lamblia or Giardia intestinalis. Gardiasis is one of the most common causes of waterborne diseases worldwide and is spread through contaminated water and food, and person to person contact. Giardia lamblia is found in animal and human feces and it can also be found in pet dogs, cats, sheep, and cattle. There are certain conditions where people infected with giardiasis never develop the signs or symptoms of this disease but still carry parasites with them and which spreads to other people.

The common symptoms of this disease includes foul smelling diarrhea with greasy stools, loss of appetite, vomiting, bloating and abdominal cramps, weight loss, abdominal pain, and nausea. Giardiasis can be diagnosed using stool sample testing and by enteroscopy, where a flexible tube is passed through the throat into the small intestine for examination of the digestive tract and to take tissue samples. At a primary level, this disease is cured without any medication; but for prolonged and severe infection, anti parasitic drugs such as metronidazole and tinidazole is prescribed for the treatment of giardiasis.

View TOC for this Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30623

Giardiasis disease is mainly spread through consumption of unhygienic water and food and through water sources contaminated with animal and human feces. The growing water pollution levels in developing and underdeveloped countries and lack of sanitation facilities in these regions is projected to drive the market for global giardiasis treatment. This disease is commonly observed among all age groups and is most frequently observed in children and their parents mainly due to the fact that nappy changing in children increases the risk of infection.

The increasing number of newborn babies in developing countries and the growing incidences of giardiasis disease in developed regions are likely to boost the demand for giardiasis disease treatment during the forecast period. However, this disease is categorized as ‘neglected disease’ by the World Health Organization as in most cases it gets treated on its own. The number of undiagnosed giardiasis disease is much higher than that of diagnosed giardiasis disease cases which seems to be the key restraining factor for the global giardiasis disease treatment market during forecast period.

The global giardiasis treatment market is broadly classified into three segments - on the basis of drug class, distribution channel, and region. Based on drug class, these are further sub segmented into Metronidazole, Tinidazole, and Nitazoxanide. Nitazoxanide is available in liquid form and is most commonly given to pediatric patients as it is easy to swallow. Nitazoxanide is projected to dominate the market during the forecast period and is likely to maintain its position till the end of 2025. Distribution channels include hospital pharmacy, retail pharmacy, and online pharmacy. Retail pharmacy is projected to account for the largest market share during the forecast period. Hospital pharmacy follows close and is projected to be the second leading contributor to the global giardiasis disease treatment market.

Fill the form to gain deeper insights on this market @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30623

In terms of geography, the global giardiasis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is likely to account for the largest market share and is projected to record highest CAGR during the forecast period. The growing population in this region, specifically in India and China, increasing incidences of waterborne disease, and unhygienic water sources would be key driving factors in this region. Europe is projected to be the second leading contributor to the giardiasis treatment market during the forecast period. North America is likely to maintain a moderate growth rate from 2017-2025.

The key players operating in the global giardiasis treatment market includes Pfizer Inc., Teva Pharmaceuticals, Baxter International Inc., Zydus Pharmaceuticals Inc., Roxane Laboratories, Inc., Heritage Pharmaceuticals Inc., Aurobindo Pharma Limited, Lupin Pharmaceuticals, Inc., and Abbott Laboratories.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Learn Details of the Global Giardiasis Treatment Market here

News-ID: 791690 • Views: 104

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Giardia

North America to lead Membrane Bioreactor System Market by 2020
Membrane bioreactor (MBR) is a combination of membrane filtration techniques such as micro filtration and ultra filtration and suspended growth bioreactor. Membrane bioreactors are used widely in large-sized wastewater treatment plants. In membrane bioreactor treatment process, membrane unit is exposed to the sludge that has been treated combine with biological process and the solid-liquid separation process together in the single stage. Membrane bioreactor system (MBR) is very effective against some
Pharmaceuticals Industry Research Report on Giardiasis Treatment Market Size & S …
The report analyzes and presents an overview of "Giardiasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" worldwide. The objectives of this study are as follows: To define, describe, and forecast the "Giardiasis Treatment" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) To analyze micromarkets with respect
Giardiasis Treatment Market Size and Key Trends in Terms Of Volume and Value 201 …
"The Latest Research Report Giardiasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This exclusive report will provide you with the market size and forecast (US$ Mn) for the global market and its segments for the period from 2015 to 2025 along with the growth rate (CAGR)
Giardiasis Treatment Market Forecast and Segments, 2017-2025
Giardiasis is a bowel infection caused by microscopic parasite known as Giardia lamblia or Giardia intestinalis. Gardiasis is one of the most common causes of waterborne diseases worldwide and is spread through contaminated water and food, and person to person contact. Giardia lamblia is found in animal and human feces and it can also be found in pet dogs, cats, sheep, and cattle. There are certain conditions where people infected
UV Disinfection Equipment Market - Fast growth of Healthcare, chemical industrie …
The UV disinfection equipment market is thriving due to the benefits associated with it including its residue-less functioning, low installation and operation cost and ease of maintenance. Request A Sample Of This Report:- http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1869 Where the government initiatives for providing safe drinking water to citizens are further increasing the scope of UV disinfection equipment, the fast growth of healthcare and chemical industries is offering opportunities for the air and surface segments of
Microbiology Automated Market: Increasing requirement, Technology Trends and Ins …
Summary: “Microbiology Automated Market” New Report to its Research Database. Order This Report by calling BigMarketResearch.com at +1-971-202-1575. Technology Review • Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. • Global listings of companies developing or marketing microbiology products by individual test. Get sample copy of http://bit.ly/2exPH5o The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews